COMPANY INSIGHT

Sponsored by HOF Sonderanlagenbau

HOF Sonderanlagenbau
Quality is key...

Hot Freeze Drying Systems -
The specialist for individual solutions.

What makes HOF unique?

Founded in 1988, HOF has developed to one of the top suppliers for pharmaceutical freeze-drying equipment, meaning freeze dryers from the laboratory scale up to production maximal production sizes, as well as specific loading and unloading devices. Furthermore, units for rapid freezing and thawing of medical and biotech products are part of our portfolio.

Nevertheless, HOF has no standard product catalogue: every system or installation is individually designed for the customer’s needs – performance parameters, space availability and room limitations as well as specified components and materials are incorporated.

“Just in time quality for our demanding customers is our valid philosophy for every single project”

The name HOF stands for…

…advise, innovation, technology, manufacture, quality and expertise. These six arguments are the fundamental basis for every project. All departments and groups involved in a customized project adjust their actions towards these criteria, always focusing on the company’s philosophy and therefore to meet all expectations towards quality, functionality and timing.

Beginning with the first Draft-Layout and the review of the ‘user requirement specification’, all parties involved work hand in hand to maximize the efficiency in the workflow and to present the best results possible. This claim is met throughout the complete runtime of a project until the final acceptance tests at the customer’s site.

What are the strengths of HOF?

Knowing that production downtimes or product losses are inacceptable for our customers and often directly connected to financial losses, active and efficient service is our main focus with customers already operating freeze-drying equipment.

In line with our philosophy, our 24-7 on call service is able to react to any kind of failure, no matter whether it is concerning a mechanical problem, wear and tear parts or software and automation issues. The combination of our warehouse with more than 60,000 different spare parts together with over 60 specifically trained service technicians is able keep downtimes to a minimum. Accordingly, the well-equipped car pool, with more than 70 vehicles, allows short reaction times. Many specific cars are already stocked with individual tools and general spares. Most of our lead technicians even take an individually assigned service vehicle home to enable short reaction times also outside of our weekly opening hours.

Service as an essential column for a reliable production also involves maintenance and recalibration on a frequent basis. In total, we service more than 1600 installations worldwide. Not only HOF products, but also products of other brands and trade names.

What do you do in order to be innovative?

For more than 25 years, HOF Sonderanlagenbau GmbH has been developing for-ward-looking technologies, nationally and internationally. An important requirement for all company departments is to develop and plan the future today. HOF employees focus on the technological innovations with the objective to meet new customers’ specific requirements.

The company’s aim for the future is to remain an innovative pioneer in research and development of freeze-drying systems. innovative charging systems, flexible shelf adjustment, use of liquid nitrogen and natural refrigerants, control integration of advanced measuring systems such as NIR and mass spectrometers, HOF SynchroFreeze and vacuum insulation: these are some examples for the company‘s innovative potential and willingness to take on new approaches.

HOF SynchroFreeze is a future oriented technology. This procedure allows a homogeneous freezing thanks to a synchronized nucleation during the freezing process – with a simultaneous reduction of the drying time.

What is the benefit of the innovation HOF SynchroFreeze?

HOF SynchroFreeze is a future oriented technology. This procedure allows a homogeneous freezing thanks to a synchronized nucleation during the freezing process – with a simultaneous reduction of the drying time.

This innovation of HOF, registered for patent approval, provides the customer with further tools to quality improvement of the pharmaceutical product and to more efficiency.
HOF SynchroFreeze distinguishes itself through a high process reliability and the possibility for retrofitting of existing freeze-drying systems.

Brief Overview of HOF SynchroFreeze:
• Synchronization of freezing process in individual vials and product containers
• Increase of the product homogeneity
• Conditioning of product structure
• Reduction of drying times

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI